TARDBP and amyotrophic lateral sclerosis: This transition was impaired in oligodendrocytes from ALS patients carrying a Tardbp mutation, rendering AMPA receptors still permeable to Ca2+ and enhancing vulnerability to excitotoxicity (Barton et al., 2021).